Clare Woodford/LinkedIn
Apr 2, 2026, 13:51
Clare Woodford: New NHS Access to Semaglutide Offers Hope to Prevent Another Stroke or Heart Attack
Clare Woodford, Head of Policy and Influencing at The Stroke Association, shared on LinkedIn:
”NICE‘s announcement that people who’ve had a stroke or heart attack and are overweight can access semaglutide on the NHS is an important development in tackling stroke and cardiovascular disease.
1 in 4 stroke survivors go on to have another stroke so this could be another vital resource in the toolbox to prevent more strokes.
Our website has more on stroke and weight loss, and steps to maintain a healthy weight.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome